OptumRx is requiring 340B covered entities to get its consent before they share OptumRx contract pharmacy claims data with drug manufacturers.
OptumRx is requiring 340B covered entities to get its consent before they share OptumRx contract pharmacy claims data with drug [...] …
Lilly told a federal appeals court its decision in the drug company's 340B contract pharmacy lawsuit "will have profound consequences for the integrity of the national healthcare system."
Lilly told a federal appeals court its decision in the company's 340B contract pharmacy lawsuit "will have profound consequences for [...] …
Groups that represent or work with 340B hospitals urged the FTC to take a closer look at PBMs' alleged discriminatory business practices.
Groups that represent or work with 340B hospitals urged the FTC to take a closer look at PBMs' alleged discriminatory [...] …
340B healthcare providers have turned to the states to address challenges to the drug discount program, 340B Report Publisher and CEO Ted Slafsky says.
340B healthcare providers have turned to the states to address challenges to the drug discount program, 340B Report's Ted Slafsky [...] …
The AHA sharply criticized a new PhRMA-funded study that says many 340B hospitals “may not offer low-income patients financial assistance to access medicines and may use extraordinary collection actions."
A new PhRMA-funded study says many 340B hospitals “may not offer low-income patients financial assistance to access medicines and may [...] …
An opinion article in the New England Journal of Medicine says overreliance on 340B drug discount revenues to fund HIV-prevention services incentivizes clinics to prescribe high-cost medicines instead of cheaper effective options. Some HIV/AIDS care providers say high drug prices are the problem, not 340B.
An opinion article in NEJM says overreliance on 340B drug discount revenues to fund HIV-prevention services incentivizes clinics to prescribe [...] …
BMS updated its 340B contract pharmacy pricing policy to address how it will handle 340B discounts on its new heart medicine Camzyos.
BMS updated its 340B contract pharmacy pricing policy to address how it will handle 340B discounts on its new heart [...] …
BMS and Merck—both for the second time this year—are giving 340B covered entities refunds for overcharges on select products.
BMS and Merck are giving 340B covered entities refunds for overcharges on select products. …
*Sign up for news summaries and alerts from 340B Report
Copyright © 2025 340B Report, LLC
Reproduction of material from any 340B Report page without written permission is strictly prohibited.
